Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View PlansCash Conversion
0.53x
POLYMED's operating cash flow covered 53% of net income in FY 2025. Some earnings may be tied up in working capital.
Free Cash Flow
₹-906.06M
POLYMED's free cash flow was negative at ₹-906.06M in FY 2025, down 728.7% from FY 2024. The company spent more on capital investments than it generated from operations.
Dividend Coverage
-3.0x
POLYMED's free cash flow did not fully cover dividends in FY 2025. The company may be funding dividends from reserves or borrowings.
CapEx Intensity
137.7%
Capital expenditure consumed 137.7% of operating cash flow in FY 2025 for POLYMED, typical of capital-intensive industries.
Hover the chart icon for YoY change.
| Item | Chart | 2024 | 2025 |
|---|---|---|---|
| Net Income | 3.44B | 4.53B | |
| Cash flow Operating Activities | 2.66B | 2.40B | |
| Investments in PPE | -2.77B | -3.31B | |
| Cash flow Investing Activities | -2.41B | -11.94B | |
| Dividend Paid | -287.40M | -303.41M | |
| Cash flow Financing Activities | -201.54M | 9.51B | |
| Cash at beginning of period | 70.62M | 120.53M | |
| Cash at end of period | 120.53M | 86.99M | |
| Free Cash Flow | -109.34M | -906.06M |
Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025